The new medical treatment to reduce encrustation and prevent the risk of infection associated with indwelling urological medical device.
Canoxidin® is an innovative solution designed to prevent the risks of complications associated with indwelled urological devices like double J stents, Foley catheters, nephrostomies or urostomies. Canoxidin® combines the action of an acidifier, the L-methionine, with crystallisation inhibitors like phytates and theobromine.
The acidification is necessary to compensate the alkalization of the urine pH, naturally associated to urologic devices indwelling. Keeping the urine pH in an acidic range promotes the generation of Nitric oxide, a bactericidal molecule.
Increasing the concentration of inhibitors in the urine prevents crystallization and the deposition of calcium and uric acid crystals on the internal and external surfaces of the urological device.
Board Member and Private Investor in different biotech start-ups. Former President of Medical Devices Committee at Catalonia Association of Biotech Companies. Master in Business Administration. Master in International Business. Master in Entrepreneurship & Innovation. BSc. Industrial Engineering. BSc. Electronic Engineering. +10 years of experience in Business Development in MD companies.
QMS Manager at Mesoestetic. Deputy Quality Manager at SANJO. PDD at IESE. Master in Business Administration. BSc in Chemical Engineering. +15 years of experience managing QA and QC in different industrial companies (pharma and automotive sectors)
Marketing Director at Rubió. Marketing Director at Lacer. Master in Business Administration. BSc in Law. +25 years in strategic marketing positions managing budgets +€20 M, sales force +300 representatives, and having launched +10 products to the market in Urology and Cardiology.
Scientific Director at AB-Biotics PhD in Microbiology BSc in Food Science and Technology BSc in Biology +15 years of experience in strategic research positions managing the development of innovative nutraceuticals and monitoring clinical trials
Financial Director at Medichem. Financial Director at Combino. Master in Financial Management. BSc in Business Administration. +20 years of experience in strategic financial positions managing budgets of +€80 M, investments of +€50 M and being in charge of the M&A of Combino by Medichem Group.
System Manager at Ficosa. R&D Manager at FTE Maximal. R&D Manager at SANYO. Master in Project Management. BSc in Telecom. Engineering. +20 years of experience in strategic R&D positions managing the development of successful products and creating R&D teams from scratch to +120 people.